Carol R. Lizak Jaguar Health, Inc. (JAGX) insider trading activity

Carol R. Lizak is Chief Financial Officer of Jaguar Health, Inc.. Currently has a direct ownership of 11,911 shares of JAGX, which is worth approximately $21,201. The most recent transaction as insider was on Dec 11, 2025, when has been sold 11,740 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.9K

177.19% 3M change

177.19% 12M change

Total Value Held $21,201

Carol R. Lizak Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 11 2025	BUY Grant, award, or other acquisition	-	11,740 Added 49.64%	11,911 Common Stock
Oct 08 2024	BUY Grant, award, or other acquisition	-	4,280 Added 49.9%	4,297 Common Stock
May 17 2024	BUY Exercise of conversion of derivative security	-	431 Added 29.26%	1,042 Common Stock
Apr 05 2024	BUY Exercise of conversion of derivative security	-	60 Added 8.94%	611 Common Stock
Aug 14 2023	BUY Grant, award, or other acquisition	-	142,088 Added 49.88%	142,745 Common Stock
May 17 2023	BUY Exercise of conversion of derivative security	-	431 Added 39.61%	657 Common Stock
Apr 05 2023	BUY Exercise of conversion of derivative security	-	60 Added 20.98%	226 Common Stock

Apr 05 2022	BUY Exercise of conversion of derivative security	-	4,513 Added 26.56%	12,481 Common Stock

CRL

Carol R. Lizak

Chief Financial Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JAGX shares.

Notify only if

Value

Insider Trading

Get notified when an Jaguar Health, Inc. insider buys or sells JAGX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Jaguar Health, Inc.

Track Activities on JAGX

Account